Hard proof of how well Oracle's main profit engine is running - join our Conference Call at 2pm CT Wednesday October 22nd. HIDE

Galena Biopharma (GALE)

Add to Watchlists
Create an Alert
1.91 +0.08  +4.37% NASDAQ Oct 21, 3:52PM BATS Real time Currency in USD

Galena Biopharma Enterprise Value:

187.26M for Oct. 20, 2014

View 4,000+ financial data types

View Full Chart

Galena Biopharma Enterprise Value Chart

Export Data
Save Image

Galena Biopharma Historical Enterprise Value Data

View and export this data going back to 2008. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Oct. 20, 2014 187.26M
Oct. 17, 2014 190.80M
Oct. 16, 2014 199.08M
Oct. 15, 2014 176.62M
Oct. 14, 2014 167.16M
Oct. 13, 2014 157.71M
Oct. 10, 2014 173.07M
Oct. 9, 2014 184.89M
Oct. 8, 2014 194.35M
Oct. 7, 2014 189.62M
Oct. 6, 2014 203.81M
Oct. 3, 2014 216.81M
Oct. 2, 2014 212.08M
Oct. 1, 2014 206.17M
Sept. 30, 2014 214.44M
Sept. 29, 2014 220.36M
Sept. 26, 2014 222.72M
Sept. 25, 2014 221.54M
Sept. 24, 2014 229.81M
Sept. 23, 2014 234.54M
Sept. 22, 2014 220.36M
Sept. 19, 2014 229.81M
Sept. 18, 2014 229.81M
Sept. 17, 2014 233.36M
Sept. 16, 2014 234.54M
Sept. 15, 2014 232.18M
Sept. 12, 2014 239.27M
Sept. 11, 2014 241.63M
Sept. 10, 2014 238.09M
Sept. 9, 2014 240.45M
Sept. 8, 2014 251.09M
Sept. 5, 2014 253.45M
Sept. 4, 2014 234.54M
Sept. 3, 2014 240.45M
Sept. 2, 2014 242.81M
Aug. 29, 2014 249.91M
Aug. 28, 2014 253.45M
Aug. 27, 2014 264.09M
Aug. 26, 2014 247.54M
Aug. 25, 2014 219.17M
Aug. 22, 2014 225.08M
Aug. 21, 2014 230.99M
Aug. 20, 2014 245.18M
Aug. 19, 2014 246.36M
Aug. 18, 2014 258.18M
Aug. 15, 2014 270.00M
Aug. 14, 2014 280.64M
Aug. 13, 2014 286.55M
Aug. 12, 2014 300.73M
Aug. 11, 2014 332.65M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for

GALE Enterprise Value Benchmarks

RXi Pharmaceuticals 25.93M
DARA Biosciences -0.2251M
Oncothyreon 69.31M

GALE Enterprise Value Range, Past 5 Years

Minimum 0.8379M Dec 19 2011
Maximum 780.64M Jan 16 2014
Average 120.63M

GALE Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GALE", "enterprise_value")
  • Last 5 data points: =YCS("GALE", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.